IBDEI31C ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,48468,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48468,1,3,0)
 ;;=3^Deformity of Musculoskeletal System,Acquired,Unspec
 ;;^UTILITY(U,$J,358.3,48468,1,4,0)
 ;;=4^M95.9
 ;;^UTILITY(U,$J,358.3,48468,2)
 ;;=^5015372
 ;;^UTILITY(U,$J,358.3,48469,0)
 ;;=M54.9^^185^2423^28
 ;;^UTILITY(U,$J,358.3,48469,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48469,1,3,0)
 ;;=3^Dorsalgia,Unspec
 ;;^UTILITY(U,$J,358.3,48469,1,4,0)
 ;;=4^M54.9
 ;;^UTILITY(U,$J,358.3,48469,2)
 ;;=^5012314
 ;;^UTILITY(U,$J,358.3,48470,0)
 ;;=M53.9^^185^2423^29
 ;;^UTILITY(U,$J,358.3,48470,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48470,1,3,0)
 ;;=3^Dorsopathy,Unspec
 ;;^UTILITY(U,$J,358.3,48470,1,4,0)
 ;;=4^M53.9
 ;;^UTILITY(U,$J,358.3,48470,2)
 ;;=^5012284
 ;;^UTILITY(U,$J,358.3,48471,0)
 ;;=M43.9^^185^2423^25
 ;;^UTILITY(U,$J,358.3,48471,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48471,1,3,0)
 ;;=3^Deforming Dorsopathy,Unspec
 ;;^UTILITY(U,$J,358.3,48471,1,4,0)
 ;;=4^M43.9
 ;;^UTILITY(U,$J,358.3,48471,2)
 ;;=^5011959
 ;;^UTILITY(U,$J,358.3,48472,0)
 ;;=R60.1^^185^2423^30
 ;;^UTILITY(U,$J,358.3,48472,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48472,1,3,0)
 ;;=3^Edema,Generalized
 ;;^UTILITY(U,$J,358.3,48472,1,4,0)
 ;;=4^R60.1
 ;;^UTILITY(U,$J,358.3,48472,2)
 ;;=^5019533
 ;;^UTILITY(U,$J,358.3,48473,0)
 ;;=R60.0^^185^2423^31
 ;;^UTILITY(U,$J,358.3,48473,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48473,1,3,0)
 ;;=3^Edema,Localized
 ;;^UTILITY(U,$J,358.3,48473,1,4,0)
 ;;=4^R60.0
 ;;^UTILITY(U,$J,358.3,48473,2)
 ;;=^5019532
 ;;^UTILITY(U,$J,358.3,48474,0)
 ;;=R60.9^^185^2423^32
 ;;^UTILITY(U,$J,358.3,48474,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48474,1,3,0)
 ;;=3^Edema,Unspec
 ;;^UTILITY(U,$J,358.3,48474,1,4,0)
 ;;=4^R60.9
 ;;^UTILITY(U,$J,358.3,48474,2)
 ;;=^5019534
 ;;^UTILITY(U,$J,358.3,48475,0)
 ;;=M72.9^^185^2423^33
 ;;^UTILITY(U,$J,358.3,48475,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48475,1,3,0)
 ;;=3^Fibroblastic Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,48475,1,4,0)
 ;;=4^M72.9
 ;;^UTILITY(U,$J,358.3,48475,2)
 ;;=^5013237
 ;;^UTILITY(U,$J,358.3,48476,0)
 ;;=M79.7^^185^2423^34
 ;;^UTILITY(U,$J,358.3,48476,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48476,1,3,0)
 ;;=3^Fibromyalgia
 ;;^UTILITY(U,$J,358.3,48476,1,4,0)
 ;;=4^M79.7
 ;;^UTILITY(U,$J,358.3,48476,2)
 ;;=^46261
 ;;^UTILITY(U,$J,358.3,48477,0)
 ;;=M84.50XA^^185^2423^36
 ;;^UTILITY(U,$J,358.3,48477,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48477,1,3,0)
 ;;=3^Fx in Neoplastic Disease,Unspec Site,Init Encntr
 ;;^UTILITY(U,$J,358.3,48477,1,4,0)
 ;;=4^M84.50XA
 ;;^UTILITY(U,$J,358.3,48477,2)
 ;;=^5014022
 ;;^UTILITY(U,$J,358.3,48478,0)
 ;;=M84.50XD^^185^2423^39
 ;;^UTILITY(U,$J,358.3,48478,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48478,1,3,0)
 ;;=3^Fx in Neoplastic Disease,Unspec Site,Routine Healing
 ;;^UTILITY(U,$J,358.3,48478,1,4,0)
 ;;=4^M84.50XD
 ;;^UTILITY(U,$J,358.3,48478,2)
 ;;=^5014023
 ;;^UTILITY(U,$J,358.3,48479,0)
 ;;=M84.50XS^^185^2423^40
 ;;^UTILITY(U,$J,358.3,48479,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48479,1,3,0)
 ;;=3^Fx in Neoplastic Disease,Unspec Site,Sequela
 ;;^UTILITY(U,$J,358.3,48479,1,4,0)
 ;;=4^M84.50XS
 ;;^UTILITY(U,$J,358.3,48479,2)
 ;;=^5014027
 ;;^UTILITY(U,$J,358.3,48480,0)
 ;;=M84.50XG^^185^2423^35
 ;;^UTILITY(U,$J,358.3,48480,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48480,1,3,0)
 ;;=3^Fx in Neoplastic Disease,Unspec Site,Delayed Healing
